Zinapar darinaparsin regulatory update

The European Commission granted Orphan Drug designation for Ziopharm's Zinapar darinaparsin to treat peripheral T cell lymphoma (PTCL). Ziopharm expects to begin a pivotal trial of the IV organic arse...